Presentation
ACI Biopesticides Europe
Spain - June 2025

Omics technologies (genomics, proteomics, metabolomics, and transcriptomics) offer powerful insights into biopesticide efficacy, safety, and environmental impact. But, can omics truly transform regulatory approval, or is their potential overstated?

Join Tom's session at 'ACI Biopesticides Europe' to understand the current role of omics in regulatory science and learn all about their challenges and future prospects.

• How omics supports mechanism of action identification and batch consistency.
• Potential for reducing reliance on animal testing in regulatory toxicology.
• Barriers to adoption: regulatory uncertainty, data complexity, and reproducibility.
• The future of omics in EFSA, EPA, and global biopesticide regulation.
• Can omics become a trusted regulatory tool or will it remain a supporting technology? 

Speaker Bio: Tom Hargreaves

Tom is a Co-Owner and Head of Agrochemical & Pharmaceutical Regulatory Compliance at Blue Frog Scientific – a consultancy recognised for its excellence and integrity in regulatory compliance.

With nearly 30 years of experience in regulatory science, Tom has worked for multiple laboratories and consultancies, helping companies navigate complex regulatory obligations. His expertise spans plant protection products and biopesticides, having played a key role in bringing some of the earliest biopesticides to the European market.

As a strategic leader, Tom brings a unique blend of science, mathematics, lateral thinking, and creativity to risk assessment and regulatory planning. His deep understanding of environmental and human health assessments ensures reliable and innovative solutions for clients.

If you're excited about the topic of omics in biopesticide regulation, and can't wait until June to talk about it... call and I'm sure we can arrange for you to speak with Tom!